VeChain (VET) Partners Bayer China to Improve Management of Clinical Trial Drugs

5007f09119678

ajax loader

VeChain and a China Focused Pharmaceutical Company Joins Hands to Improve Management of Clinical Trial Drugs 350x209 1

On May 28, 2020, Bayer China, a leading company in the Chinese pharmaceutical scene,  revealed plans of co-developing a Clinical Trial Traceability Platform based on the VeChain blockchain called cSecure. This solution monitors user and product data ensuring consistency throughout the trial of clinical drugs thereby improving precision and safety.  VeChain and Bayer China Deal

Add a Comment

Your email address will not be published. Required fields are marked *

Do NOT follow this link or you will be banned from the site!